Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ALT
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 29, 2026 | ALT Altimmune, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Oct 27, 2026 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 27, 2026 | ALT Altimmune, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 29, 2026 | ALT Altimmune, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 12, 2026 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 28, 2026 | ALT Altimmune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 28, 2026 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 16, 2026 | ALT Altimmune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 13, 2026 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 24, 2026 | ALT Altimmune, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 16, 2026 | ALT Altimmune, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 16, 2026 | ALT Altimmune, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 5, 2026 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 3, 2026 | ALT Altimmune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 28, 2026 | ALT Altimmune, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 19, 2025 | ALT Altimmune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 19, 2025 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 1, 2025 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 1, 2025 | ALT Altimmune, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 6, 2025 | ALT Altimmune, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 6, 2025 | ALT Altimmune, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 6, 2025 | ALT Altimmune, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Nov 6, 2025 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 6, 2025 | ALT Altimmune, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 3, 2025 | ALT Altimmune, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 25, 2025 | ALT Altimmune, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Aug 12, 2025 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 26, 2025 | ALT Altimmune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 26, 2025 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 13, 2025 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 13, 2025 | ALT Altimmune, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| May 13, 2025 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2025 | ALT Altimmune, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 13, 2025 | ALT Altimmune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 27, 2025 | ALT Altimmune, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 27, 2025 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 25, 2025 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 25, 2025 | ALT Altimmune, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 11, 2024 | ALT Altimmune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 12, 2024 | ALT Altimmune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2024 | ALT Altimmune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | ALT Altimmune, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
43 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:23 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances